Molecular Health announced today that its chief innovation officer, David Jackson, Ph.D., will speak at this year’s Personalized Medicine World Conference, Silicon Valley. Dr. Jackson’s presentation, titled, “From Knowledge Innovation to Personalized Pharmacovigilance,” will highlight how the integrated computational analysis of genetic, pharmacological and clinical parameters can be used to identify safer effective treatment options for cancer patients.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
